Search for: "USA v. Hatch"
Results 1 - 20
of 122
Sorted by Relevance
|
Sort by Date
26 Sep 2013, 9:33 pm
Teva Pharmaceuticals USA, Inc. [read post]
25 Nov 2015, 9:59 pm
Noonan -- The question of the extent to which the "safe harbor" against infringement as part of the Hatch-Waxman Act (set forth in 35 U.S.C § 271(e)(1)) extends to activities post-generic drug approval is unresolved, as evidenced by the different conclusions in Classen Immunotherapies, Inc. v. [read post]
27 Jul 2013, 9:40 pm
Strafford will be offering a webinar/teleconference entitled "Inducement to Infringe in Hatch-Waxman Litigation: Lessons from Commil USA v. [read post]
12 Jul 2013, 8:44 pm
Strafford will be offering a webinar/teleconference on "Inducement to Infringe in Hatch-Waxman Litigation: Lessons from Commil USA v. [read post]
12 Oct 2010, 9:59 pm
§ 2201) in the Hatch-Waxman context in Teva Pharmaceuticals USA, Inc. v. [read post]
17 May 2023, 8:53 am
In Corcept Therapeutics, Inc. v. [read post]
17 May 2023, 8:53 am
In Corcept Therapeutics, Inc. v. [read post]
17 May 2023, 8:53 am
In Corcept Therapeutics, Inc. v. [read post]
8 Oct 2020, 9:59 pm
Noonan -- The back-and-forth, (almost) cat-and-mouse-like competition between branded innovator and generic drug makers sanctioned under the Hatch-Waxman Act has been on-going for over thirty years. [read post]
17 Aug 2010, 9:42 am
Alcon, Inc. v. [read post]
4 Aug 2013, 9:29 pm
August 5-7, 2013 - Advanced Patent Law Seminar (Chisum Patent Academy) - Seattle, WA August 8, 2013 - Analyzing and Adapting to the Supreme Court's Myriad Ruling (Technology Transfer Tactics) - 1:00 to 2:00 pm (Eastern) August 8-11, 2013 - 2013 Annual Meeting (American Bar Association) - San Francisco, CA August 21, 2013 - Inducement to Infringe in Hatch-Waxman Litigation: Lessons from Commil USA v. [read post]
18 Aug 2013, 8:42 pm
August 20, 2013 - Licensing Self-Replicating Technologies after Monsanto (Intellectual Property Owners Association) - 2:00 to 3:00 pm (ET) August 21, 2013 - Inducement to Infringe in Hatch-Waxman Litigation: Lessons from Commil USA v. [read post]
11 Aug 2013, 7:35 pm
August 21, 2013 - Inducement to Infringe in Hatch-Waxman Litigation: Lessons from Commil USA v. [read post]
16 Jan 2021, 8:38 am
By Memorandum Opinion entered in Allergan USA, Inc. et al. v. [read post]
18 Dec 2023, 10:00 pm
USA, Inc. , 7 F.4th 1320 (Fed. [read post]
26 Nov 2008, 7:57 am
"AstraZeneca Pharmaceuticals LP v. [read post]
20 Feb 2013, 7:37 am
Bristol-Myers Squibb Company v. [read post]
31 Jan 2012, 4:09 am
The case is entitled Carey v. 24 Hour Fitness USA Inc. [read post]
24 Jan 2012, 6:34 pm
Labs. v. [read post]
20 Aug 2020, 9:59 pm
Noonan -- ANDA litigation, pursuant to the Hatch-Waxman Act, has become more complicated over the years since enactment of the statute in 1984, with more patents being asserted and more parties participating over the opportunity to market a generic version of a branded, innovator drug. [read post]
